[KYMR] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 42.91%
YoY- 30.07%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 18,519 18,702 12,785 14,533 3,288 3,428 1,833 368.00%
PBT -24,660 -13,075 -12,685 -7,986 -13,989 -10,932 -11,513 66.24%
Tax 98 118 -373 125 228 349 300 -52.60%
NP -24,660 -13,075 -12,685 -7,986 -13,989 -10,932 -11,513 66.24%
Tax Rate - - - - - - - -
Total Cost 43,179 31,777 25,470 22,519 17,277 14,360 13,346 118.90%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -133.16 -69.91 -99.22 -54.95 -425.46 -318.90 -628.10 -64.47%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 64.86%
EPS Diluted -0.55 -0.29 -0.29 -0.18 -0.32 -0.25 -0.26 64.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.